首页> 外文期刊>Thyroid Research >Association of thyroid function with arterial pressure in normotensive and hypertensive euthyroid individuals: A cross-sectional study
【24h】

Association of thyroid function with arterial pressure in normotensive and hypertensive euthyroid individuals: A cross-sectional study

机译:血压正常和高血压的甲状腺功能正常者甲状腺功能与动脉压的关系:一项横断面研究

获取原文
       

摘要

Background Overt hypothyroidism has been associated with arterial hypertension and increased arterial stiffness. Results in euthyroid individuals have been conflicting. We investigated associations of thyroid function with systolic (SAP) and diastolic (DAP) arterial pressure in euthyroid subjects. Methods 311 euthyroid individuals (185 women, mean age 43.9 ± 9) without a history of diabetes attending a preventive medicine program were examined. Subjects receiving thyroxine (10.6%) were excluded; 19.3% had hypertension, 43% had a family history for hypertension. TSH, fT4, thyroid autoantibodies, insulin, glucose were measured. The "fT4.TSH product", which has been suggested as a T4 resistance-index, was calculated. Results TSH range was 0.1–8, median 1.4 mU/L, fT4 range was 11.5–25.2 pmol/L, median 17.4. TSH and the "fT4.TSH product" were positively associated with DAP (p 2 mU/L (35.3% vs 21.3%, p = 0.045). Conclusion In euthyroid individuals the association of thyroid function with diastolic arterial pressure remains significant even when a stricter "normal range" for TSH levels is considered. The "freeT4.TSH" product appears to be an even stronger predictor of DAP, independently of HOMA insulin resistance index and obesity.
机译:背景明显的甲状腺功能减退症与动脉高血压和动脉僵硬度增加有关。甲状腺功能正常者的结果一直存在矛盾。我们调查了甲状腺功能正常的受试者的甲状腺功能与收缩压(SAP)和舒张压(DAP)的关联。方法检查311名没有糖尿病史的甲状腺功能正常的人(185名女性,平均年龄43.9±9),参加了预防医学项目。排除接受甲状腺素(10.6%)的受试者;有高血压的人占19.3%,有家族病史的人占43%。测量了TSH,fT4,甲状腺自身抗体,胰岛素,葡萄糖。计算出建议作为T4电阻指数的“ fT4.TSH产物”。结果TSH范围为0.1–8,中位数为1.4 mU / L,fT4范围为11.5–25.2 pmol / L,中位数为17.4。 TSH和“ fT4.TSH产物”与DAP呈正相关(p 2 mU / L(35.3%vs 21.3%,p = 0.045)。结论在甲状腺功能正常的个体中,即使在以下情况下,甲状腺功能与舒张动脉压的相关性仍然显着TSH水平的严格“正常范围”被认为是“ freeT4.TSH”产物似乎是DAP的更强预测因子,与HOMA胰岛素抵抗指数和肥胖无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号